Back to drug list

Nexviazyme (avalglucosidase alfangpt)


Billing

Code: J0219

Description: Inj aval alfa-nqpt 4mg

Unit: 4 mg

Payment: $72.506

Pay quarter: Q1 2023


Medicare history

Dosage and Frequency

Pompe disease

• 20mg/kg IV every 2 weeks if patient weighs 30kg or more
• 40mg/kg IV every 2 weeks if patient weighs less than 30kg

Calculate drug reimbursement


Total Reimbursement:

$30,742.54

(ASP: $29,002.40, Margin: $1,740.14)


Code:

J0219

# Units to bill:

400

Prior Authorization

Prior auth criteria for Nexviazyme may include but is not limited to:





Insurance prior auth guidelines:


Billable NDCs

58468-0426-01

Nexviazyme (GENZYME CORPORATION)

100 mg



Resources